Cite
HARVARD Citation
Zhang, T. et al. (2020). A randomized phase 2 trial of pembrolizumab versus pembrolizumab and acalabrutinib in patients with platinum‐resistant metastatic urothelial cancer. Cancer. 126 (20), pp. 4485-4497. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zhang, T. et al. (2020). A randomized phase 2 trial of pembrolizumab versus pembrolizumab and acalabrutinib in patients with platinum‐resistant metastatic urothelial cancer. Cancer. 126 (20), pp. 4485-4497. [Online].